Saskatoon, SK

The Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac)

Project Details

Value:

$116 Million

Completion:

2012

Size:

130,000 sq. ft.

Services:

Prime Consulting, Architecture, Interior Design, Construction Contract Administration

The Vaccine and Infectious Disease Organization – International Vaccine Centre (VIDO-InterVac), located on the University of Saskatchewan (USask) campus, stands as one of North America’s largest research institutes for vaccine and infectious disease research at containment levels 2 and 3. The Centre is Canada’s sole research facility equipped with containment level 3 (CL3) large animal capacity. A collaborative endeavor between USask and VIDO, this state-of-the-art CL3Ag biocontainment facility serves as a vital hub for studying various animal and human diseases, both existing and emerging.

Boasting a diverse team of researchers hailing from over 20 countries, VIDO-InterVac offers a dynamic learning environment for undergraduates, postgraduates, and postdoctoral fellows, comprising approximately one-third of its staff. Beyond its cutting-edge facilities, the center’s unique resources and expertise are accessible to public and private stakeholders, as well as commercial partners. This broad appeal allows InterVac research teams to attract top-tier national and international researchers and students, fostering extensive opportunities for collaborative research.

The facility revolves around large animal containment research (AP3-LA) and containment level 3 research laboratories (AP3/CL3). It also encompasses supporting containment level 2 laboratories (CL2), spaces for research, teaching, and training, administrative areas, and operations and logistics sections.

This project was a joint venture with Architecture49 (formerly Smith Carter Architects).


Awards and Publications

  • Premier’s Award of Excellence in Design, Award of Merit (2011)